Results 261 to 270 of about 411,291 (407)
Mitochondrial targets in ischaemic heart disease and heart failure, and their potential for a more efficient clinical translation. A scientific statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function
European Journal of Heart Failure, EarlyView.Improving clinical translation of mitoprotective therapies. 31P MRI, phosphorus‐31 magnetic resonance imaging; hiPSC‐CM, human‐induced pluripotent stem cell‐derived cardiomyocyte; IHD, ischaemic heart disease. Abstract
Acute myocardial infarction (MI) remains a major cause of death and disability worldwide.Melanie Paillard, Mahmoud Abdellatif, Ioanna Andreadou, Christian Bär, Luc Bertrand, Bianca J.J.M. Brundel, Gemma Chiva‐Blanch, Sean M. Davidson, Dana Dawson, Fabio Di Lisa, Paul Evans, Zoltan Giricz, Derek J. Hausenloy, Petra Kleinbongard, Frank Lezoualc'h, Elisa Liehn, Christoph Maack, Ange Maguy, Elizabeth Murphy, Cinzia Perrino, Maurizio Pesce, Peter P. Rainer, Katrin Streckfuss‐Bömeke, Matthias Thielmann, Rong Tian, Carlo G. Tocchetti, Jolanda Van Der Velden, Sophie Van Linthout, Serena Zacchigna, Thomas Krieg +29 morewiley +1 more sourceReversing the “risk‐treatment paradox” of bleeding in patients undergoing percutaneous coronary intervention: Risk‐concordant use of bleeding avoidance strategies is associated with reduced bleeding and lower costs [PDF]
, 2018 Amin, Amit P, Bach, Richard, Caruso, Mary, Crimmins-Reda, Patricia, Kulkarni, Hemant, Kurz, Howard, Lasala, John M, Miller, Samantha, Pierce, Andrew, Rahn, Brandon, Singh, Jasvindar, Sorensen, Katrine, Zajarias, Alan +12 morecore +1 more sourceAetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE‐TR registry
European Journal of Heart Failure, EarlyView.Aetiological phenotypes of secondary tricuspid regurgitation. AF, atrial fibrillation; HFpE, heart failure with preserved ejection fraction; CARE‐TR, Consecutive pAtients with seveRE Tricuspid Regurgitation evaluated in Heart Failure and Valve Clinics; HF, heart failure; HFmrEF, heart failure with mildly reduced ejection fraction; HFrEF, heart failure ...Laura Lupi, Elena Antonioli, Angelica Praderio, Alessandro Villaschi, Elisa Soranzo, Nicola Saccani, Kamil Stankowski, Daniele Cocianni, Beniamino Pagliaro, Valeria Magni, Marco Loffi, Daniela Tomasoni, Matteo Pagnesi, Antonio Mangieri, Davide Stolfo, Gianfranco Sinagra, Marianna Adamo, Marco Metra +17 morewiley +1 more sourceUpdated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.
JACC: Cardiovascular Interventions, 2019 D. Sibbing, D. Aradi, D. Alexopoulos, J. T. ten Berg, Deepak L. Bhatt, L. Bonello, J. Collet, T. Cuisset, Francesco Franchi, L. Gross, P. Gurbel, Y. Jeong, R. Mehran, D. Moliterno, F. Neumann, N. Pereira, M. Price, M. Sabatine, D. So, G. Stone, R. Storey, U. Tantry, D. Trenk, M. Valgimigli, R. Waksman, D. Angiolillo +25 moresemanticscholar +1 more sourceDIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT‐HF): Baseline characteristics compared to recent randomized controlled heart failure trials
European Journal of Heart Failure, EarlyView.Effects of digitoxin compared to placebo on efficacy and safety in patients with heart failure and reduced ejection fraction (HFrEF). Primary endpoint: time to all‐cause death and first hospitalization for worsening heart failure (whatever occurs first). ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin Udo Bavendiek, Nele Henrike Thomas, Dominik Berliner, Xiaofei Liu, Johannes Schwab, Andreas Rieth, Lars S. Maier, Sven Schallhorn, Eleonora Angelini, Samira Soltani, Fabian Rathje, Mircea‐Andrei Sandu, Welf Geller, Thomas Gaspar, Rainer Hambrecht, Marija Zdravkovic, Sebastian Philipp, Dragana Kosevic, Georg Nickenig, Daniel Scheiber, Sebastian Winkler, Peter Moritz Becher, Philipp Lurz, Martin Hülsmann, Maria von Karpowitz, Christoph Schröder, Barbara Neuhaus, Anika Seltmann, Heiko von der Leyen, Christian Veltmann, Stefan Störk, Michael Böhm, Armin Koch, Anika Großhennig, Johann Bauersachs, on behalf of the DIGIT‐HF Study Group +35 morewiley +1 more sourceCardiac resynchronization therapy for enabling guideline‐directed medical therapy optimization in heart failure
European Journal of Heart Failure, EarlyView.Cardiac resynchronization therapy (CRT) as an enabler for guideline‐directed medical therapy (GDMT) in the Swedish Heart Failure Registry (SwedeHF). The figure summarizes the selection of the study population, changes in GDMTs and loop diuretic use/doses from baseline to 1.5‐year follow‐up in patients receiving versus not receiving CRT, and reports the Daniela Tomasoni, Lina Benson, Paolo Gatti, Alessandro Villaschi, Charlotta Ljungman, Marco Metra, Raffaele Scorza, Frieder Braunschweig, Michael Melin, Giuseppe Rosano, Michael Böhm, Javed Butler, William T. Abraham, Wilfried Mullens, Fredrik Gadler, Cecilia Linde, Lars H. Lund, Gianluigi Savarese +17 morewiley +1 more sourceLiver stiffness measurement for non‐invasive assessment of central venous pressure in patients with heart failure: A multicentre pilot study
European Journal of Heart Failure, EarlyView.Liver stiffness measurement for central venous pressure assessment. AUC, area under the curve; BMI, body mass index; CI, confidence interval; CVP, central venous pressure; HF, heart failure; LSM, liver stiffness measurement; LVEF, left ventricular ejection fraction. Abstract Aims
Central venous pressure (CVP) is an important variable in assessing heart Nicolas Girerd, Jan Biegus, Adam Janas, Piotr Buszman, Marcin Suska, Ovidiu Chioncel, Julie Foucquier, Anne Llorca, Laura Cantu Sanchez, Marat Fudim, Kevin Damman, Maria Rosa Costanzo, Beth Davison, Gad Cotter, Laurent Sandrin, Victor de Lédinghen, Alexandre Mebazaa +16 morewiley +1 more source
